98%
921
2 minutes
20
Although recent advances in treatment of traumatic olfactory dysfunction, which had a low rate of improvement through treatment, have increased the improvement rate in younger patients, it remains low in middle-aged and older patients. Although olfactory function declines with age, its impact on traumatic dysfunction recovery remains unclear. This study was conducted to investigate the effects of aging on olfactory nerve regeneration and olfactory function recovery in an animal model of traumatic olfactory injury. Behavioral experiment using olfactory preference and morphological measurements were performed on OMP-tau-lacZ mice at 3 months, 1.0 year and 1.5 years old, in which the olfactory nerve can be visualized after X-gal staining. In the behavioral experiments, we measured the time required for mice to search for and find a piece of potato chip hidden under the cage bedding. The head trauma model included a bilateral olfactory nerve transection (BNTx) group and a control craniotomy alone without BNTx group. In each age and surgery group, behavioral olfactory tests were performed 6 weeks (42 days) and 1.0 year (365 days) after surgery. The reinnervation of olfactory nerve axons to the olfactory bulb was then assessed in histological tissue samples from the mice. The older BNTx group performed worse in behavioral tests than the younger BNTx group, and reinnervation of olfactory nerve axons to the olfactory bulb was lower in the older BNTx group. These findings suggest that aging leads to poor olfactory nerve axon regeneration and poor recovery of olfactory function after olfactory nerve transection injury.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.neuroscience.2025.05.005 | DOI Listing |
Brain
September 2025
IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, 40139, Italy.
An early diagnosis of Parkinson's disease (PD) represents a challenge and novel accurate biomarkers are therefore urgently needed. Detection of phosphorylated α-synuclein (p-α-syn) in skin nerve fibers has shown promise as such a marker. However, its accuracy for the identification of PD among patients with early signs of parkinsonism has not been thoroughly explored.
View Article and Find Full Text PDFVestn Otorinolaringol
September 2025
Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences» a separate division of the «Research Institute of Medical Problems of the North, Krasnoyarsk, Russia.
Relevance: Acute rhinosinusitis is one of the most common ENT diseases. Topical complex nasal spray Polydexa with phenylephrine (PE), which includes an aminoglycoside antibiotic, is effective as a local therapy. There are no data on the toxic effects of Polydexa with PE in the medical literature.
View Article and Find Full Text PDFZhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
August 2025
Department of Otolaryngology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
To investigate the transcriptomic signature of refractory nasal polyps (NP) after endoscopic sinus surgery. Tissue samples were collected from 36 patients with NP who underwent endoscopic sinus surgery at the Seventh Affiliated Hospital of Sun Yat-sen University and the First Affiliated Hospital of Sun Yat-sen University from January 2020 to December 2021. Raw sequencing data of normal nasal mucosa samples were downloaded from publicly available GEO database (Accession Number: GSE136825).
View Article and Find Full Text PDFFront Neurosci
August 2025
Department of Biomedical Sciences, Rocky Vista University College of Osteopathic Medicine, Englewood, CO, United States.
The prevalence of neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) in the U.S. is expected to increase as the population ages.
View Article and Find Full Text PDFNeurol Res Pract
August 2025
Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, 6020, Austria.
Objective: To assess the role of spectral domain Optical Coherence Tomography (OCT) as a biomarker in Huntington's disease (HD).
Methods: This cross-sectional study compared spectral domain OCT data, cognitive function, and olfactory function in HD patients and healthy controls (HC). HD patients were classified into Stage1 and Stage2 based on motor symptoms and functional capacity.